About us Contacts Drug interactions: 390 212
Drug search by name

Diflucan (Fluconazole Injection Solution) and Rifadin IV

Determining the interaction of Diflucan (Fluconazole Injection Solution) and Rifadin IV and the possibility of their joint administration.

Check result:
Diflucan (Fluconazole Injection Solution) <> Rifadin IV
Relevance: 15.11.2022 Reviewer: Shkutko P.M., M.D., in

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer:

RifAMPin may reduce the blood levels of fluconazole, which may make the medication less effective in treating your infection. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or more frequent monitoring to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Professional:

MONITOR CLOSELY: Coadministration with rifampin may decrease the plasma concentrations of fluconazole. The precise mechanism of interaction has not been established, but may involve rifampin induction of fluconazole metabolism via CYP450 isoenzymes, although fluconazole is not extensively metabolized but is primarily (approximately 80%) eliminated unchanged by the kidney. Two pharmacokinetic studies--one in healthy volunteers and one in AIDS patients with cryptococcal meningitis--demonstrated less than 25% decreases in mean fluconazole systemic exposure (AUC) during coadministration with rifampin 600 mg daily. The clinical significance of these changes is uncertain. In the study with AIDS patients, no significant differences in clinical outcomes were observed between the group that received fluconazole (400 mg/day) with rifampin and the group that received fluconazole without rifampin. However, serum concentrations of fluconazole were generally lower than the minimum inhibitory concentration for Cryptococcus neoformans in the rifampin group when fluconazole dosage was subsequently reduced to 200 mg/day for maintenance therapy, which could theoretically diminish its efficacy in the long-term prevention of recurrence. A more recent study conducted in Ugandan HIV patients treated with fluconazole 800 mg/day for cryptococcal meningitis found no difference in mean steady-state fluconazole plasma levels in patients who received concomitant rifampin therapy relative to those who did not. Nonetheless, there have been isolated reports of suspected interaction in the medical literature describing diminished therapeutic effects of fluconazole in the presence of rifampin, including clinical relapse of cryptococcal meningitis following the addition of rifampin in three HIV patients treated with fluconazole 400 mg/day. Another report describes 2 critically ill patients receiving concomitant fluconazole (100 and 200 mg/day) and rifampin therapy (1200 mg/day) whose fluconazole AUC was 52% lower than in 3 ICU patients given similar dosages of fluconazole without rifampin. Likewise, in a study of azole antifungal agents with various CYP450 inducers, a 44% reduction in fluconazole AUC was observed in a single patient receiving fluconazole 100 mg with rifampin 1200 mg daily. One study also suggests that the decrease in fluconazole concentrations with concurrent rifampin therapy is associated with a decrease in the efficacy of fluconazole in the treatment of oral candidiasis in AIDS patients. Based on available data, it would appear that the risk of a clinically significant interaction may be increased in patients receiving lower dosages of fluconazole and/or higher dosages of rifampin.

MANAGEMENT: Closer clinical monitoring of fluconazole therapy may be warranted whenever starting, stopping, or increasing the dosage of rifampin. Depending on clinical circumstances, consideration should be given to increasing the dosage of fluconazole.

References
  • Cerner Multum, Inc. "Australian Product Information." O 0
  • Rajasingham R, Meya DB, Boulware DR "Are fluconazole or sertraline dose adjustments necessary with concomitant rifampin?" HIV Med 19 (2018): e64-5
  • Tett S, Carey D, Lee H-S "Drug interactions with fluconazole." Med J Aust 156 (1992): 365
  • Strayhorn VA, Baciewicz AM, Self TH "Update on rifampin drug interactions, III." Arch Intern Med 157 (1997): 2453-8
  • Jaruratanasirikul S, Kleepkaew A "Lack of effect of fluconazole on the pharmacokinetics of rifampicin in AIDS patients." J Antimicrob Chemother 38 (1996): 877-80
  • Nicolau DP, Crowe HM, Nightingale CH, Quintiliani R "Rifampin-fluconazole interaction in critically ill patients." Ann Pharmacother 29 (1995): 994-6
  • Panomvana Na Ayudhya D, Thanompuangseree N, Tansuphaswadikul S "Effect of rifampicin on the pharmacokinetics of fluconazole in patients with AIDS." Clin Pharmacokinet 43 (2004): 725-32
  • Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  • "Product Information. Diflucan (fluconazole)." Roerig Division, New York, NY.
  • Coker RJ, Tomlinson DR, Parkin J, et al "Interaction between fluconazole and rifampicin." Br Med J 301 (1990):
  • Tucker RM, Denning DW, Hanson LH, et al "Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations." Clin Infect Dis 14 (1992): 165-74
  • Apseloff G, Hilligoss DM, Gardner MJ, et al "Induction of fluconazole metabolism by rifampin: in vivo study in humans." J Clin Pharmacol 31 (1991): 358-61
Diflucan (Fluconazole Injection Solution)

Generic Name: fluconazole

Brand name: Diflucan

Synonyms: Diflucan

Rifadin IV

Generic Name: rifampin

Brand name: Rifadin IV, Rifadin, Rimactane

Synonyms: n.a.

In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.